Bristol-Myers Squibb Co
NYSE:BMY

  • LAST PRICE
    58.7800
  • TODAY'S CHANGE (%)
    -0.0900 (-0.1529%)
  • Bid / Lots
    58.6600/ 2
  • Ask / Lots
    58.7900/ 3
  • Open / Previous Close
    59.9800 / 58.8700
  • Day Range
    58.6300
    60.6800
  • 52 Week Range
    39.3500
    61.0800
  • Volume
    13,919,208

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BMY
Bristol-Myers Squibb Co
119.4B
-16.3x
+4.90%
SNY
Sanofi SA
123.8B
25.8x
+4.55%
GSK
GSK plc
70.0B
22.4x
+6.39%
AZN
AstraZeneca PLC
204.4B
31.9x
+17.52%
PFE
Pfizer Inc
145.4B
35.2x
-7.10%
GILD
Gilead Sciences Inc
112.4B
1,077.5x
+1.53%
As of 2024-11-25

Company Information

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

Contact Information

Headquarters
Route 206 And Province Line RoadPRINCETON, NJ, United States 08543
Phone
609-252-4621
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Chief Operating Officer
Christopher Boerner
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
David Elkins
President, Cell Therapy Organization, Member of the Leadership Team
Lynelle Hoch
Chief Human Resource Officer, Executive Vice President, Member of the Leadership Team
Amanda Poole
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Greg Meyers

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$119.4B
Revenue (TTM)
$47.4B
Shares Outstanding
2.0B
Dividend Yield
4.08%
Annual Dividend Rate
2.4000 USD
Ex-Dividend Date
10-04-24
Pay Date
11-01-24
Beta
0.45
EPS
$-3.60
Book Value
$14.56
P/E Ratio
-16.3x
Price/Sales (TTM)
2.5
Price/Cash Flow (TTM)
40.7x
Operating Margin
-12.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.